Avadel Pharmaceuticals | 424B5:募资说明书
Avadel Pharmaceuticals | 8-K:重大事件
Avadel Pharmaceuticals | 10-Q:季度报表
Avadel Pharmaceuticals | 8-K:Avadel Pharmicals提供公司最新情况并报告2024年第一季度财务业绩
Avadel Pharmaceuticals | 3:首次持股声明-高管 Seurer Jerad G.
Avadel Pharmaceuticals | 10-K/A:年度报表(修正版)
Avadel Pharmaceuticals | 8-K:重大事件
Avadel Pharmaceuticals | 8-A12B:证券登记/上市
Avadel Pharmaceuticals | 8-K:重大事件
Avadel Pharmaceuticals | 8-K:Avadel Pharmicals 提供公司最新情况并报告 2023 年第四季度和全年财务业绩
Avadel Pharmaceuticals | 4:持股变动声明-高管 Kim Richard J
Avadel Pharmaceuticals | 4:持股变动声明-高管 MCHUGH THOMAS S
Avadel Pharmaceuticals | 4:持股变动声明-高管 Divis Gregory J
Avadel Pharmaceuticals | 10-K:年度报表
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(12.4%)
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Jeffrey L. Gendell(6.33%),Tontine Asset Associates, LLC(3.94%)等
Avadel Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Polar Capital Holdings Plc(7.51%),Polar Capital LLP(7.51%)
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Kevin Kotler(4.1%)
Avadel Pharmaceuticals | 4:持股变动声明-高管 MCHUGH THOMAS S
暂无数据